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Abstract
Biological membranes are organized in various microdomains, one of the best known being called membrane 
rafts. The major function of these is thought to organize signaling partners into functional complexes. An im-
portant protein found in membrane raft microdomains of erythroid and other blood cells is MPP1 (membrane 
palmitoylated protein 1)/p55. MPP1 (p55) belongs to the MAGUK (membrane-associated guanylate kinase 
homolog) family and it is a major target of palmitoylation in the red blood cells (RBCs) membrane. The well-
known function of this protein is to participate in formation of the junctional complex of the erythrocyte mem-
brane skeleton. However, its function as a “raft organizer” is not well understood. In this review we focus on 
recent reports concerning MPP1 participation in membrane rafts organization in erythroid cells, including its 
role in signal transduction. Currently it is not known whether MPP1 could have a similar role in cell types other 
than erythroid lineage. We present also preliminary data regarding the expression level of MPP1 gene in several 
non-erythroid cell lines. (Folia Histochemica et Cytobiologica 2019, Vol. 57, No. 2, 43–55)
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Introduction
The red cell membrane comprises a lipid bilayer 
with integral membrane proteins embedded in it and 
a membrane skeleton. During its 120 days life in the 
circulation the red blood cell undergoes cyclic me-
chanical shear and deforming stresses in the blood 
stream, in particular during passages through capillary 
vessels, which often are four times smaller in diam-
eter than the larger diameter of the erythrocyte. As 
the lipid bilayer is essentially devoid of extensibility 
and mechanical resistance (but characterized by high 
linear elasticity), which results in rapid vesiculation 
under even mild shear stress, an essential role in 
maintaining erythrocyte membrane mechanical 
properties plays membrane skeleton, whose structure 
and function have been a subject of many studies and 
reviews [1–3]. The erythrocyte membrane bilayer is 
not homogeneous; it is characterized by relatively 
high cholesterol content (> 20% lipids by weight) and 
a set of lipids including sphingolipids (sphingomyelin 
(SM) and glycolipids) which participate in the gener-
ation of membrane lateral heterogeneity by forming 
domains among which lipid or membrane rafts have 
been attracting the attention of many laboratories. 
Literature up to 2014 was surveyed in the previous 
review [4]. The question remains whether membrane 
rafts are functional or just remnants of the early stages 
of nucleated cells. Despite several years of research, 
there is no great progress towards answering this 
question. For example, as was mentioned previously 
[4] there have been several raft-dependent signaling 
pathways found in red blood cells, e.g. Gsa-protein 
coupled b-adrenergic receptors cAMP-kinase A lead-
ing to the phosphorylation of adducin [5, 6]. Still the 
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erythrocyte membrane remains an interesting object 
of the study of lateral membrane organization and its 
function. An example of interesting studies concerns 
binding of amyloid beta by erythrocyte membrane 
and its connection with Alzheimer’s disease. A fluo-
rescence correlation spectroscopy (FCS)-based study 
[7] revealed that fluorescently labeled amyloid peptide 
(Ab1-42) localizes to erythrocyte membrane nanodo-
mains which were suggested to be caveolin-rich.
Due to its relative simplicity, erythrocyte mem-
brane still remains a very attractive object to study 
lateral membrane heterogeneity, i.e. organization of 
nanodomains. Despite long-term studies we still do 
not know the molecular mechanisms of how they are 
organized or even an apparently simpler question, 
i.e. whether we are dealing with single or multiple 
kinds of domains in this simple membrane. This 
issue was addressed by Leonard et al. [8], who via 
Laurdan-general polarization (GP) studies detected 
separate nanodomains enriched in SM present in the 
red blood cell membrane regions of low curvature and 
cholesterol enriched in the regions of high curvature. 
Our studies described below focused on one possible 
mechanism of lateral membrane organization regu-
lation in which peripheral membrane palmitoylated 
protein 1 (MPP1) was found to play a crucial role, so 
the considerations presented below concern presenta-
tion of the model of this mechanism and address the 
question of how specific the presented mechanism is, 
and whether it operates only in blood/erythroid cells 
or is common in mammals.
Membrane raft concept
Spatiotemporal organization of biological membranes 
is characterized by dynamic lateral heterogeneity, as 
proven by many biophysical and biochemical observa-
tions. One of the best known and most acknowledged 
forms of this heterogeneity is the existence of lateral 
subcompartments, called membrane rafts (lipid rafts) 
— a concept formulated by Simons and Ikonen in 
1997 [9] which has been the subject of detailed current 
reviews [10–12].
The basic assemblies, which for clarity in this 
text will be called resting state rafts, are domains 
which are highly dynamic (t1/2 ~ 1 s and ~20 nm 
in diameter), formed by lo phase lipid and a set of 
characteristic proteins some of which are permanent 
residents of these domains (e.g. stomatin and flo-
tillins) while other are temporarily associated with 
these domains (e.g. growth factor receptors, H-Ras 
protein, GPI-anchored proteins), which is connected 
with their activation or resting state. The lipid com-
ponent of vertebrate cell membrane rafts, enriched 
in sphingolipids and cholesterol together with other 
membrane phospholipids which contain long-chain, 
mostly saturated alkyl residues, is in the so-called 
liquid ordered phase. Although the molecular basis of 
lateral phase separation in model membranes seems 
relatively well understood, available data concerning 
biological mechanism(s) controlling Ld (liquid dis-
ordered) — (liquid ordered) phase separation and 
formation of rafts in natural membranes are rather 
scarce and permit only general hypotheses. Lateral 
interactions of cholesterol with membrane raft-spe-
cific lipids seem to be crucial for maintaining these 
microdomains in the ‘lo’, liquid-ordered state, which 
is characterized by decreased conformational (trans-
gauche) freedom and, consequently, reduced “fluidi-
ty”, compared to the bulk, containing less cholesterol, 
membrane, which exists in the ‘ld’ (liquid disordered) 
state. However, unlike the gel phase in artificial lipid 
systems they are characterized by similar (within the 
same range) lateral (translational) mobility to the lo 
membrane phase, as was measured by FRAP tech-
nique on plasma membranes [13–15].
The detergent-resistant membrane (DRM) frac-
tion is defined as a low-density, insoluble in cold no-
nionic detergent solution membrane fraction floating 
at 5/30% sucrose step gradient. It was suggested to 
be useful in assigning potential raft association when 
changes in the composition are induced by physiolog-
ically meaningful events. However, it is possible that 
DRMs may represent an artificial coalescence of raft 
proteins and lipids into a residue that does not exist 
in living cells. Therefore, although there is no simple 
relationship between DRM and membrane rafts, 
DRM isolation and characterization is still considered 
a useful tool, providing some insight into their lateral 
organization [16, 17].
The molecular basis of Chol:SM complex forma-
tion is the hydrogen bond between the amide group 
of sphingolipid and the hydroxyl group of cholesterol 
and also the interaction of cholesterol with saturated 
alkyl chains. Cholesterol is thought to interact with 
saturated long alkyl chains of other phospholipids. It 
should be noted that data on lipidomics of the DRMs 
reveal that, in addition to the abundance of sphingo-
lipids (mostly sphingomyelin), cholesterol and gly-
colipids, they contain other phospholipids, including 
some species of PE and PS that mostly contain fully 
saturated or monounsaturated acyl chains. Predomi-
nant among these are the phosphatidylethanolamine 
glycerophospholipids and plasmalogens [18]. Phos-
phatidylserine, which is a relatively minor membrane 
component, is three times more prevalent in the DRM 
than in the bulk volume of the plasma membrane, 
while phosphatidylinositols are rather diminished 
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within the DRM, as are phosphatidylcholine species. 
PEs occur in the membrane predominantly as sn-1 
saturated, sn-2 unsaturated glycerophospholipids, 
and experimental data show that some DRM prepa-
rations are enriched in 1-stearoyl-2-linoleoyl-sn-glyce-
ro-3-phosphoethanolamine (SLPE), regardless of the 
method of isolation [18]. Our own data indicate that 
this PE interacts with cholesterol comparably to SM, 
while dipalmitoyl-PE does not bind cholesterol [19]. 
This suggests the importance of the structure of acyl 
chains of particular phospholipids (not all of which 
are saturated) and also explains the background of 
the mechanism by which inner-layer phospholipids 
participate in membrane rafts.
Membrane rafts contain several specific sets of 
membrane proteins [20], which include membrane 
proteins belonging to the SPFH family (stomatin/ 
/prohibitin/flotillin/HflK), such as raft scaffold pro-
teins flotillin-1 and -2, and stomatin or stomatin-like 
protein. These proteins share a common feature in 
that they associate with raft domains, possibly through 
cholesterol binding or oligomerization [21]. Apart 
from these proteins, and other palmitoylated and 
transmembrane proteins, membrane rafts also include 
GPI-anchored proteins and integral and peripheral 
proteins involved in signal transduction.
Many of the raft proteins are modified with 
saturated acyl (palmitoyl) chains, or with cholester-
ol, which is thought to facilitate interactions with 
lo-domains [22]. The mechanism(s) by which the 
proteins partition into membrane rafts may involve 
preferred solubility in the ordered domains and/or 
chemical affinity for raft lipids, as exemplified by the 
above-mentioned cholesterol-binding properties of 
some of the proteins [23]. Other examples include 
a structural protein motif recognizing sphingolipids 
or specific glycolipids such as ganglioside [24].
It has long been known that rafts are engaged 
in cellular signal transmission pathways by hosting 
a number of receptors and their associated adapter 
proteins, and also facilitate signaling switches during 
activation of the respective pathways. These proteins 
include receptor tyrosine kinases (EGF-R, IGF-1 
receptor), non-receptor kinases (e.g. src kinases: Src, 
Lck, Hck, Fyn, Blk, Lyn, Fgr, Yes, and Yrk [25]), 
serpentine (G-protein-linked seven transmembrane 
domain) receptors [26], sigma receptors [27] and the 
growth factor receptor c-kit, as well as heterotrimeric 
and monomeric G-proteins and other adaptor pro-
teins. Also endothelial nitric oxide synthase, hedgehog 
protein and pro- or anti-apoptotic signaling elements 
have been found in raft domains, as was reviewed 
[28]. Of particular interest are the potential roles of 
membrane rafts as signaling platforms in neoplasia 
[29] and their possible use as targets for anticancer 
drugs [28].
The catalogue of physiological functions of rafts 
involves several important biological processes, and 
some of them have been shortly described below. 
1. Immune signaling involving several innate and 
adaptive immune responses. These processes have 
been studied for more than 20 years, beginning 
with the discovery of involvement of rafts in IgE 
signaling [30]. Many components of the immune 
reactions such as FceR1, T cell receptor and B cell 
receptor move from non-raft (detergent sensitive 
membrane) to the raft (DRM) upon activation. 
The DRM fraction was also found to be enriched 
in signal transduction machinery which includes 
LCK and FYN kinases and LAT protein and also 
GPI anchored proteins such as CD14 or THY1 
(CD90) [31]. Formation of the so-called immune 
synapse is considered an example of a “raft sig-
naling platform”, a relatively stable structure in 
diameter in the micrometer range.
2. Host-pathogen interactions. For example, the raft 
domain is suggested to be a site for HIV budding, 
binding [32] and stabilization of rafts by cholera 
toxin (Ctx) and Shiga toxin (Stx) [33, 34]. Also 
VacA, a vacuolating toxin of H. pylori, predomi-
nantly associates with the raft phase; however, this 
binding was found to be independent of oligom-
erization and pore-forming activity [10, 35]. For 
example, an interesting observation was published 
recently indicating that H. pylori expression of the 
cgt gene encoding cholesterol-a-glucosyltransfer-
ase reduces cholesterol levels in infected gastric 
epithelial cells, which disrupts membrane rafts, 
blocking in turn IFNg signaling, allowing bacteria 
to escape the host inflammatory response [36].
3. In cancer cells, as mentioned above, a considerable 
number of receptors and adapter proteins involved 
in signaling pathways engaged in proliferation 
were found in the DRM fraction, suggesting the 
crucial role of these structures for signaling of 
these aberrant cells’ development. The literature 
reviewing various aspects of this subject is particu-
larly rich [27–29]. Some of the signaling pathways 
and processes could become a target for cancer 
treatment by using raft domain disrupting agents, 
as was reviewed previously [28].
4. Involvement in other pathologies. In atheroscle-
rosis, transition of macrophages into foam cells 
following uptake of ox-LDL is raft dependent as 
ox-LDL receptors localize to raft domains [37, 
38]. Other data [39] suggest that lipid-free apoA-I 
mediates beneficial effects through attenuation of 
immune cell membrane raft cholesterol content, 
,
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which affects numerous types of signal transduc-
tion pathways that rely on microdomain integrity 
for assembly and activation. On the other hand, 
it was found [40] that 7-dehydrocholesterol, but 
not cholesterol or other sterols, promotes lipid 
raft/caveolae formation, leading to suppression 
of canonical TGF-b signaling and atherogenesis.
An important and mostly unresolved question 
is how the raft domains are organized. In a sense, 
it predominantly concerns domains corresponding 
to “resting state rafts” defined by Hancock [41], i.e. 
functional, more stable domains, > 20 nm in diam-
eter. The model proposed by Hancock assumes that 
in cell membranes the smallest nanocomplexes of the 
so-called membrane rafts precursors, which are built 
of several protein molecules and lipids, are unstable 
structures and they disintegrate in milliseconds, 
but when they are connected in larger structures of 
approximately 20 nm, they become more stable and 
functional microdomains and so-called ‘resting rafts” 
[42]. These microdomains can be further associated in 
structures through protein-protein [43] and protein-li-
pid interactions with a diameter larger than 100 nm, 
called signaling platforms. In their stabilization, 
the membrane or cell skeleton is involved. Recent 
hypotheses concerning membrane raft organization/ 
/regulation presented in several reviews [10, 41, 44, 
45] include: 
1. Lipid–lipid interactions, which include preferential 
cholesterol binding with sphingolipids [46] and 
possibly other lipids such as gangliosides [47] or 
saturated/di- or more unsaturated amino phos-
pholipids [19];
2. Lipid–protein interactions, such as proteins mod-
ified by cholesterol [48], e.g. PSD95 [49], MPP1 
[4] discussed herein, or by sphingolipid-binding 
[50] motifs. There are even suggestions that 
proteins which are secreted from the cells bind-
ing a2-3-sialyllactose common in the glycans of 
monosialogangliosides regulate lateral membrane 
organization. According to Dalton et al. [51], sol-
uble klotho binding of gangliosides reduces the 
propensity of membrane to form large ordered 
domains for endocytosis, which downregulates 
PI3K signaling.
3. We should add protein-protein interactions, an 
example of which is MPP1-flotillins and/or pos-
sibly other raft residing proteins such as ABCC4 
reported recently by Pitre et al. [52];
4. Hydrophobic match or mismatch; it is hypothet-
ically possible that integral proteins of longer 
transmembrane domain (TMD) would segregate 
into lipid domains containing longer fatty acid 
chains. A solidifying effect of transmembrane 
peptides of longer TMD and a liquifying effect of 
shorter TMD peptides were reported previously 
by Killian et al. [53];
5. Actin-skeleton-driven mechanisms. Cortical ac-
tin skeleton is widely considered to affect lateral 
membrane organization since it has been shown 
to affect molecular diffusion (hop and trapped 
diffusion) and supramolecular arrangements in 
the membrane [54, 55]. Stabilization of nanome-
ter sized domains by an actin filament meshwork 
was suggested by several groups [56, 57]. Also an 
interesting approach is a technique of giant plas-
ma membrane vesicles (GPMVs) which provides 
a model of membrane devoid of membrane/or cor-
tical actin skeleton. This membrane shows phase 
separation at the micrometer scale [58–60]. Also 
in the case of erythroid cells liquid-liquid phase 
separation in the plasma membrane devoid of 
spectrin-actin skeleton either via extraction with 
alkaline solution or treatment with latrunculin 
takes place [61], which somewhat contradicts the 
statements presented at the beginning of this par-
agraph. Certainly, keeping the raft domain small 
(~20 nm) in most of the resting state cells may be 
connected with the presence of membrane/cortical 
actin skeleton, which might be in agreement with 
the picket-fence model.
In general, involvement of single or multiple 
protein-protein and or protein-lipid interactions in 
the organization and regulation of membrane rafts 
would imply the possibility of regulation at the cellular 
and/or tissue level. Knowledge of such interactions 
and their regulation may lead to understanding the 
molecular mechanism of raft domain organization 
and regulation and, moreover, may provide ways 
for manipulation of such processes which would be 
useful in therapeutic approaches. At this moment, the 
number of possible proteins engaged in the process 
of raft domain organization is limited and in the Pu-
bMed database we can find only about 6–7 proteins/ 
/genes which are suspected to be involved in “flat” 
(non-caveolae) raft domain organization. These are 
flotillin-1 and -2, annexin A2, C-type lectin domain 
family 2 member (Clec2i), epithelial membrane pro-
tein-2 (Emp2), Pacsin2 (protein kinase C and casein 
kinase substrate in neurons 2), raftlin (Rftn1) and 
calpactin (S100a10). 
Membrane palmitoylated protein 1 
Our previous studies [61] on red blood cell rafts led 
us to the hypothesis that MPP1 and its palmitoyla-
tion play a crucial role in lateral membrane organ-
ization in erythroid cells. Membrane palmitoylated 
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protein 1 (MPP1/p55) encoded by the MPP1 gene 
belongs to the MAGUK family (membrane asso-
ciated guanylate kinase homologs) [62, 63]. MPP1 
(p55), a MAGUK family member, was first cloned 
by Ruff et al. [64] and identified as a major target 
of palmitoylation in red blood cell membrane. It 
partially fulfills the criteria for scaffolding protein, 
in that it contains several functional domains which 
are potentially responsible for simultaneous binding 
of regulatory and skeletal proteins and is, therefore, 
an important protein of the membrane skeleton ter-
nary complex (for review see Machnicka et al. [1]). 
MPP1 shares single GUK, SH3 and PDZ domains 
and contains a D5/Hook/I3 domain which is respon-
sible for protein 4.1R binding (Fig. 1) [65]. MPP1 
has the ability to stabilize mechanical properties 
of red blood cell membrane by the formation of a 
tripartite complex with protein 4.1 and glycophorin 
C linking the spectrin-based membrane skeleton to 
the membrane bilayer, which is the best known role 
of MPP1. In this role, the PDZ domain of MPP1 
interacts with the cytoplasmic domain of glyco-
phorin C, while the central region (D5- domain) is 
responsible for interaction with protein 4.1R [65, 
66]. This interaction markedly strengthens protein 
4.1-glycophorin C binding [67].
MPP1 is involved in resting state raft  
formation in erythroid cells
The functional role of MPP1 palmitoylation is cur-
rently not well understood but it is believed that 
MPP1 palmitoylation is a crucial event involved in 
raft formation, which might be linked to pathology [4, 
28, 61]. Studies performed on erythroid precursor cell 
line HEL cells revealed that following inhibition of 
palmitoylation by treatment with the potent protein 
acetyltransferase (PAT) inhibitor 2-BrP (2-bromo 
palmitate), the amount of DRM fraction was mark-
edly decreased. When a stable HEL cell-line with 
silenced expression of the MPP1 gene was used for 
experiments, the same effect was observed. Moreover, 
fluorescence lifetime imaging microscopy (FLIM) 
experiments using di-4 probe performed on normal 
and 2-BrP-treated HEL cells and HEL cells with 
stably silenced MPP1 expression demonstrated a sig-
nificant decrease in membrane order upon inhibition 
of palmitoylation, or a decrease in cellular MPP1 level 
[61, 68]. The key role of MPP1 protein in the lateral 
membrane organization has also been demonstrated 
in model systems which are GPMV vesicles derived 
from living cells. As a model GPMVs were used, ob-
tained from HEL cells (control and MPP1 KnD) [68]. 
Numerous studies indicate that the biochemical com-
position of GPMVs to a significant degree represents 
their original membranes [58, 69] and also reflects 
the native membrane structure. The results from the 
research on giant plasma membrane, performed by 
using several advanced microscopic methods using 
order-sensing probes, such as C-Laurdan and di-4, 
showed that, in erythroid cell-membrane derived 
vesicles, MPP1 plays an important role in maintaining 
proper order of the membrane [68]. Moreover, the 
presence of this protein stabilizes the liquid-ordered 
phase, as observed in the higher miscibility transition 
temperature of separated vesicles. 
In conclusion, changes in membrane fluidity are 
caused by MPP1, in the absence of major changes in 
membrane lipid composition, as the fluidity of pure 
lipids extracted from GPMV membranes remained 
unchanged and MPP1 recovery in KnD cells leads to 
the re-establishment of plasma membrane organiza-
tion [68]. Furthermore, MPP1 knockdown significant-
ly affects the activation of MAP-kinase signaling via 
raft-dependent tyrosine kinase receptors, indicating 
the importance of MPP1 for lateral membrane organ-
ization [61]. Further studies showed that, in HEL cells 
with MPP1 knock-down, the changes in the plasma 
membrane led to the disruption of signaling cascades 
from the activated insulin receptor. The signal inhibi-
tion occurs at the level of H-Ras, as we did not observe 
GDP-to-GTP exchange upon insulin treatment [70]. 
FLIM-FRET microscopy studies revealed impaired 
interaction of H-Ras with its effector molecule, Raf, in 
insulin-treated MPP1-knockdowned cells, confirmed 
by changes in H-Ras lateral diffusion revealed by 
FRET analysis (Fig. 2). Moreover, in these cells its 
lateral mobility was not sensitive to insulin treatment. 
Taken together, our data suggest a relationship be-
tween MPP1-dependent plasma-membrane organi-
zation and H-Ras activation [70]. 
MPP1 interacts with different proteins 
As mentioned above, MPP1 forms a tripartite complex 
with the 4.1R protein and glycophorin C [71, 72]. Pro-
Figure 1. Domain structure of the membrane palmitoylated 
protein 1 (MPP1). PDZ — postsynaptic density-95 /discs 
large/zonula occludens-1 domain; SH3 — src Homology 
3 Domain; D5 — domain contains the binding site for the 
FERM domain of protein 4.1R; GUK — catalytically inactive 
guanylate kinase (GuK) domain. Based on data presented 
in [61, 66]. 
48 Magdalena Trybus et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2019
10.5603/FHC.a2019.0007
www.fhc.viamedica.pl
tein 4.1 of red blood cells (4.1R) is a multifunctional 
protein that is localized in the membrane skeleton 
and stabilizes erythrocyte shape and membrane 
mechanical properties, such as deformability and 
stability, via lateral interactions with spectrin, actin, 
glycophorin C and protein p55 (See reviews: 1, 2, 
73). Evidence that MPP1 interacts with protein 4.1 
has been shown in the work of Marfatia et al. [72]. 
Patients with genetic defects resulting in the absence 
of protein 4.1 (4.1[-] hereditary elliptocytosis) or with 
defect of glycophorin C (Leach elliptocytosis) also 
showed absence of MPP1. It indicates that MPP1 is 
associated, in precise proportions, with the protein 
4.1-glycophorin-C complex, linking the skeleton and 
the membrane. MPP1 contains a binding sequence 
for the FERM (4.1, ezrin, radixin, moesin) domain 
of protein 4.1R [74]. 
Further studies on molecular partners of MPP1 in 
the erythrocyte membrane by using different methods, 
such as chemical cross-linking of membrane proteins, 
co-immunoprecipitation, overlay and solid phase 
pull-down assays as well as in situ proximity assay, led 
to the identification of novel interactions of MPP1 
and flotillin 1 and flotillin 2 (raft-marker proteins) in 
the erythrocyte membrane [75]. These interactions 
are under further, detailed kinetic exploration in 
a model system and confirm high affinity of formation 
of these complexes (Olszewska et al. to be published). 
These interactions were shown to be separate from the 
above-mentioned well-known protein 4.1-dependent 
interactions with MPP1 membrane proteins [61]. Flo-
tillins are membrane-associated proteins [76] which 
are functional in different cellular processes, including 
clustering of membrane receptors, regulation of sign-
aling pathways [77, 78], participation in cell adhesion 
[79] and interactions with the cytoskeleton [79]. The 
mechanism underlying their clustering remains unclear.
Furthermore, it is known that MPP1 interacts with 
Discs large protein P-dlg (DLG5). P-dlg is a protein 
encoded by the P dlg gene and is a human homolog 
of the Drosophila dlg tumor suppressor gene. This 
protein has three PDZ domains in contrast to MPP1, 
Dlg-2 and Dlg-3, an SH3 domain and a GUK domain, 
which are conserved structures in some MAGUK fam-
ily proteins [80]. Interaction between P-dlg and the 
GUK domain of MPP1 protein has been confirmed 
by yeast two-hybrid screening [80]. The C-terminal 
portion of MPP1 (289–466) has four internal T/S-X-V 
motifs which may be binding sites for the PDZ domain 
of P-dlg [80]. It is also interesting that MPP1 is highly 
Figure 2. Localization of mEGFP-HRas and mRFP-RBD in non-stimulated and insulin-treated cells. 1 × 106 control, scramble 
and MPP1 KnD cells were transfected with the appropriate plasmids (0.5 μg each) using CLB (Lonza) electroporation. After 
24 hours, cells were serum-starved for 20 hours and transferred onto glass coverslips coated with 0.1 mg/ml poly-L-lysine. Cells 
were observed in a chamber at 37° C and 5% CO2. Photographs were taken before and after addition of insulin [1 μg/ml], 
5 min after stimulation. A. Representative images, scale bar 10 μm. B. Relative fluorescence intensity profiles revealed 
impaired recruitment of mRFP-RBD (effector molecule) to the plasma membrane by H-Ras in insulin-treated MPP1 KnD 
cells (+insulin) — right panel. Reproduced from ref. 70, Podkalicka et al. 2018 (Creative Commons Attribution 3.0 License). 
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abundant in AML (acute myeloid leukemia) cells, 
and interacts with the ABC transporter, ABCC4. The 
studies by Pitre et al. [52] showed that the expression 
of MPP1 highly correlated with ABCC4 expression in 
AML, and moreover, it was also associated with poor 
prognosis for AML patients. The authors carried out 
an assessment of all PDZ-binding domain proteins 
on the oligonucleotide microarray with samples from 
the diagnostic leukemic blasts of 130 pediatric AML 
patients. They found 81 single PDZ-domain proteins. 
Analysis (using a correlation with ABCC4 of >  0.4 as 
a threshold) led to the identification of 11 single-PDZ 
domain proteins that fulfilled the criteria. The MPP1 
gene met all requirements with both the highest 
correlation with ABCC4 (r = 0.84) in the studied 
AML data sets. Further research carried out by this 
group also showed that the PDZ domain is necessary 
and sufficient to bind ABCC4. Furthermore, MPP1 
regulates ABCC4 plasma membrane location and 
affects stability of ABCC4. Further research of this 
group indicated that this protein interaction is readily 
disrupted by a small molecule, antimycin A [52].
The role of MPP1 in non-erythroid cells is under-
stood rather poorly. Mburu et al. [81] have shown 
that MPP1 forms a complex with whirlin, the protein 
which binds the Usher protein network in the coch-
lea and the Crumbs network in the retina, by direct 
association with USH2A (usherin) and VLGR1 
(a member of the 7-transmembrane receptor G-protein, 
which binds calcium and is expressed in the central 
nervous system). One of the established physiological 
roles of MPP1 is its involvement in the regulation of 
neutrophil polarity. A MPP1 knockout (p55-/-) mouse 
model [82] showed that, upon agonist stimulation of 
neutrophils, MPP1 is rapidly recruited to the leading 
edge. Neutrophils of knockout mouse do not migrate 
efficiently in vitro and form multiple pseudopods upon 
chemotactic stimulation, in contrast to normal mouse 
neutrophils, which form a single pseudopod at the cell 
front required for efficient chemotaxis. Phosphoryla-
tion of Akt is decreased in these cells upon stimulation 
with chemoattractant, and this appears to be mediated 
by a PI3Kg kinase-independent mechanism [82]. 
A similar effect was observed in flotillin-1 KO mouse 
[79], which showed a significant decrease in flotillin 2. 
Another example is interaction of MPP1 with the 
FERM domain of NF2 protein. NF2 is a cytoskeletal 
protein also called merlin, schwannomin or neurofi-
bromin 2 [65]. Neurofibromatosis type 2 (NF2) is 
a tumor-prone disorder characterized by the develop-
ment of multiple schwannomas and meningiomas [83]. 
MPP1-NF2 protein interaction may play a functional 
role in the regulation of apicobasal polarity and tumor 
suppression pathways in non-erythroid cells [65].
MPP1 interacts with cholesterol and lipids
It should be noted that there is also a possibility of 
MPP1-lipid, mainly cholesterol interactions. We used 
a simple bioinformatics approach to establish whether 
MPP1 is capable of binding cholesterol. Modeled and 
experimentally validated fragment structures were 
mined from online resources and searched for CRAC 
and CRAC-like motifs. Several of these motifs were 
found in the primary structure of MPP1, and these 
were structurally visualized to see whether they local-
ized to the protein surface. Since all of the CRAC and 
CRAC-like motifs were found at the surface of MPP1 
domains, in silico docking experiments were per-
formed to assess the possibility of interaction between 
CRAC motifs and cholesterol. The obtained results 
show that MPP1 can bind cholesterol via CRAC and 
CRAC-like motifs with moderate to high affinity (KI 
in the nano- to micro-molar range). It was also found 
that palmitoylation-mimicking mutations (C/F or 
C/M) did not affect the affinity of MPP1 towards cho-
lesterol [84]. Further studies on recombinant MPP1 
interactions in simple Langmuir monolayer technique 
revealed that injection of MPP1 into the subphase of 
an LB monolayer composed of DOPC/SM/Chol (1:1:1 
molar ratio) induced an increase in surface pressure, 
indicating that MPP1 molecules were incorporated 
into the lipid monolayer. The compressibility modu-
lus isotherms of MPP1, lipids and lipid-MPP1 films 
have essentially different shapes from one another. In 
addition, this interaction was found to be sensitive to 
the presence of cholesterol in the lipid monolayer, as 
adding MPP1 to the subphase of lipid monolayers con-
taining cholesterol resulted in a much larger increase 
in surface area than when MPP1 is injected into the 
subphase of a lipid monolayer devoid of cholesterol 
[85]. Moreover, MPP1-bound cholesterol was found 
to competitively inhibit surface pressure changes of 
the phospholipid monolayer [86]. 
MPP1 is the resting state raft organizing 
protein in erythroid cells
In conclusion, we propose MPP1 to be a main com-
ponent of the mechanisms responsible for lateral 
organization of the erythroid cell membrane. The 
studies presented above indicate a new role for MPP1, 
and present a novel linkage between membrane raft 
organization and their function. 
The molecular mechanism underlying MPP1’s 
function as a resting state raft organizer remains to be 
explored. Our hypothesis is that, upon palmitoylation, 
the affinity of MPP1 for binding to the pre-existing 
nanocluster membrane increases. As preexisting na-
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noclusters we consider protein-cholesterol/lipid com-
plexes corresponding to short-lived (half time < 0.1 ms) 
nanocomplexes (< 10 nm in diameter), described pre-
viously by others [87–89]. This suggestion is based on 
the observations that in HEL cells, upon inhibition of 
palmitoylation, all MPP1 remains in the high-density 
“skeletal” fraction within the density-gradient profile 
of the DRM, and also MPP1 KnD Hel cell membrane 
is characterized by increased membrane fluidity as 
measured by FLIM of the D-4 probe. We believe that 
flotillin-1 and -2 are important components of these 
nanoclusters, which was confirmed by the fact that flo-
tillins are found in the DRM residual fraction even after 
treatment with beta methyl cyclodextrin. Binding of 
palmitoylated MPP1 to the pre-existing nanocomplexes 
via flotillins and perhaps via cholesterol-binding regions 
as was recently documented [75, 84–86] induces their 
fusion and stabilizes them as membrane resting-state 
rafts, which are larger (~20 nm) in diameter [90], more 
stable (~1 s), detergent-resistant, and which become 
functional (see Fig. 3).
MPP1 is not the raft organizer in most cells 
in mammalian organisms
As the data on the level of MPP1 protein in the 
various cell types of the human body are only 
fragmentary (e.g. https://www.ncbi.nlm.nih.gov/ 
/gene/4354), we decided to test the presence of 
MPP1 in several human cell types. First of all we 
completed screening through blood cells. Cells were 
isolated from whole blood on the density gradient 
Ficoll-Paque (density 1.077 g/mL) and then further 
purified using MicroBeads by Miltenyi Biotec. The 
level of MPP1 gene expression in the studied cells 
was assessed by Western blot analysis and RT-PCR 
(reverse transcription). Additionally, in some cases 
the effect of palmitoylation on the formation of 
DRM fractions was tested on these cells (Table 1). 
For this purpose, a palmitoylation inhibitor, 2-BrP, 
was used. The DRM fraction was isolated via cold 
1% Triton X-100 extraction and ultracentrifugation 
of the extract on a sucrose step (40/30/5%) gradient. 
Literature data indicated the presence MPP1 in 
erythroid cells, mouse granulocytes and several my-
eloid and lymphoid cell lines. In our experience high 
expression of MPP1 could be observed in most blood 
cells and blood cell-derived neoplastic cell lines. As 
could be anticipated, a relatively high level of MPP1 
could be detected in the platelets as their parental 
cell has a common precursor with erythrocytes. In 
the blood cells the amount of DRM fraction protein 
and cholesterol and first of all the presence of MPP1 
in the DRM appeared to be sensitive to inhibition 
Figure 3. Schematic model of the proposed mechanism of resting state membrane raft organization in erythroid cells. Free 
MPP1 which is in equilibrium with membrane skeletally associated pool of this protein binds to the pre-existing short-lived 
flotillins-based nano-assemblies (< 10 nm in diameter, half time < 0.1 ms). This leads to oligomerization and co-assembly 
of flotillin-based nanoclusters into larger-scale complexes and formation of a more stable (half time ~1 s) larger (> 20 nm) 
structures called “resting state rafts” in erythroid cell membrane. Modified from Biernatowska et al. [75]) (CC BY-NC-ND 4.0).
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of palmitoylation with 2-BrP (Table 1) as was the 
fluidity of the cell membrane in vivo, as measured 
via FLIM analysis of the di-4 probe. However, to our 
surprise, the MPP1 gene was not expressed to high 
levels in studied cells of human tumor-derived cell 
lines apart from HEK293 (human embryonic kidney). 
In the latter cells an easily detectable signal was ob-
served via either RT-PCR or Western blot, although 
dependence upon palmitoylation of DRM localiza-
tion of MPP1 could not be observed in the applied 
experimental conditions. We have to keep in mind 
that the remaining cell lines are derived from human 
tumors, so we cannot anticipate with a high degree of 
certainty that in the case of normal tissues the results 
would be the same. In the case of blood cells most of 
the neoplastic cells expressed the MPP1 gene at a high 
level, but in some of them (promyelocytic leukemia 
HL60 or Raji Burkitt’s lymphoma) MPP1 could not 
be detected in Western blot. 
The obtained results clearly show that MPP1 is 
expressed at a negligible level in many types of human 
cancer epithelial cells, in contrast to cells of erythroid 
origin, where the level of their expression is high. The 
results support the hypothesis that the MPP1 protein 
is not responsible for the formation and maintenance 
of membrane rafts in epithelial cells, and this may sug-
gest a different model of formation of these domains 
than in the erythroid cells.
Conclusions
The data collected by us clearly indicate that MPP1 
participates in the resting state membrane rafts’ or-
ganization and regulation at least in erythroid cells. 
Summarizing collected information about membrane 
raft formation and the role of MPP1, we conclude that 
a network of proteins involving flotillins and flotill-
in-binding proteins is responsible for bringing lipids 
closely enough to form small, relatively stable (~1 s) 
lo phase domains which form resting-state rafts which 
are functional in the sense of recruiting appropriate 
activated (or becoming activated after becoming 
a part of the raft) receptors and other elements of the 
signaling pathway. It may also facilitate dissociation 
Table 1. The presence of MPP1 protein or its mRNA in different cell types




DRM DRM sensitivity to 2-BrP 
treatment
Changes of fluorescence  
life-time of di-4 probe
Erythrocytes +++ +++A +++ +++ +++
HEL +++ +++ +++ +++ +++
K562 +++ +++ +++ +++ nd
Thrombocytes +++ +++ nd nd nd
Monocytes +++ +++ nd nd nd
Neutrophils +++ +++ nd nd nd
Jurkat T +++ nd +++ +++ +++
HL60 +/– nd nd nd nd
HEK293 ++ nd – – – – nd
MDA-MB-231 +/– + – – nd
HeLa – – nd nd nd
A549 – – nd nd nd
A375 – – nd nd nd
SCOV3 – – nd nd nd
MCF7 – – nd nd nd
DU145 – – nd nd nd
AReticulocyte +++ present; – absent; nd — not determined. The localization in DRM fractions and/or sensitivity to 2-BrP treatment are also 
presented. Cells or cell lines were cultured in standard conditions. For Western blot analyses, cells were dissolved in Laemmli buffer and subjected 
to SDS-PAGE, transferred onto nitrocellulose filter, blocked with 5% milk proteins and probed with anti-MPP1 rabbit antibodies (Aviva Systems 
Biology, San Diego, CA, USA) and developed with appropriate secondary antibody conjugated to horseradish peroxidase in a chemiluminescent 
reaction. Reverse transcriptase (RT) reaction was performed using isolated total RNA (miRNeasy kit QIAGEN, Hilden, Germany) translated into 
cDNA via RT reaction (RevertAid First Strand cDNA Synthesis Kit Thermo Fisher Scientific, Waltham, MA, USA). Primers for MPP1 (Genomed, 
Warsaw, Poland; FP: CCTACGAGGAAGTCGTTCGG, RP: GGTCTGGGGCTCAATGTCAA, 340 bp, and for beta-actin Thermo Fisher Scientific: 
FP; TACAATGAGCTGCGTGTGGCTCCCG, RP: AATGGTGATGACCTGGCCTGGCCGTCAGGC, 540 bp) were used.
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of certain elements of the signaling pathway from the 
raft domain upon their activation, e.g. H-Ras disso-
ciating from the raft domain after exchange of GDP 
for GTP. Effects of MPP1 knock-out on neutrophil 
polarization or interaction with ABBC4, which causes 
a significant increase in cell resistance to chemother-
apy, may also be connected with MPP1’s resting state 
raft organizing role.
Our preliminary results indicate that the MPP1 
protein is abundant only in blood cells and their 
precursors, in other cells such as HEK293 there is 
a smaller amount of this protein, whereas in breast 
cancer cells such as MDA-MB-231 we observed only 
trace amounts of MPP1. The data collected by us may 
suggest that there may be more than one mechanism 
of the formation of membrane rafts. Our hypothesis 
assumes that another MAGUK protein or even pro-
teins which do not belong to the MAGUK protein 
family may perform a similar function as MPP1. For 
example, a similar function was recently suggested 
for the palmitoylation of Rac1 in COS-7 and MEF 
cells [91], and these authors implicate a role for the 
actin cytoskeleton in the mechanism of raft clustering 
in these cells. Therefore, the answer to the question 
posed by the title at this stage of research is that the 
MPP1-based molecular mechanism of resting state 
raft domain organization is a mechanism limited to 
certain types of cells, and the question of such domain 
organization in other cells remains open. However, we 
anticipate that it could be a flotillin-binding protein 
based mechanism.
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